CPTP
Basic information
Region (hg38): 1:1324756-1328896
Previous symbols: [ "GLTPD1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CPTP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 29 | 35 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 7 | 0 |
Variants in CPTP
This is a list of pathogenic ClinVar variants found in the CPTP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-1326921-C-T | not specified | Likely benign (Feb 17, 2023) | ||
1-1326951-T-C | not specified | Uncertain significance (Jan 22, 2024) | ||
1-1326986-G-A | not specified | Uncertain significance (Dec 28, 2023) | ||
1-1327001-C-T | not specified | Uncertain significance (Sep 27, 2024) | ||
1-1327302-C-T | not specified | Uncertain significance (Mar 17, 2023) | ||
1-1327303-G-A | not specified | Likely benign (Nov 21, 2022) | ||
1-1327311-G-T | Uncertain significance (Apr 27, 2019) | |||
1-1327315-G-A | not specified | Uncertain significance (Jan 21, 2025) | ||
1-1327317-C-T | not specified | Uncertain significance (May 11, 2022) | ||
1-1327348-G-A | not specified | Uncertain significance (Nov 21, 2022) | ||
1-1327364-G-T | not specified | Uncertain significance (May 31, 2023) | ||
1-1327371-C-T | not specified | Likely benign (Feb 06, 2023) | ||
1-1327374-G-A | not specified | Uncertain significance (Jun 04, 2024) | ||
1-1327387-G-A | not specified | Likely benign (Dec 08, 2023) | ||
1-1327413-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
1-1327416-C-G | not specified | Uncertain significance (Oct 20, 2021) | ||
1-1327425-T-A | not specified | Uncertain significance (Mar 28, 2024) | ||
1-1327434-C-T | not specified | Uncertain significance (Aug 27, 2024) | ||
1-1327446-C-T | not specified | Uncertain significance (Apr 14, 2022) | ||
1-1327447-G-A | not specified | Uncertain significance (Nov 26, 2024) | ||
1-1327488-G-A | not specified | Uncertain significance (Nov 11, 2024) | ||
1-1327494-C-T | not specified | Uncertain significance (Jul 20, 2022) | ||
1-1327506-G-A | not specified | Uncertain significance (Apr 14, 2022) | ||
1-1327512-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
1-1327515-C-T | not specified | Uncertain significance (Jun 25, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CPTP | protein_coding | protein_coding | ENST00000343938 | 2 | 4142 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0225 | 0.778 | 125497 | 0 | 18 | 125515 | 0.0000717 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0932 | 158 | 155 | 1.02 | 0.0000115 | 1357 |
Missense in Polyphen | 53 | 53.078 | 0.99853 | 511 | ||
Synonymous | -1.01 | 88 | 76.7 | 1.15 | 0.00000602 | 464 |
Loss of Function | 0.928 | 3 | 5.31 | 0.565 | 2.26e-7 | 57 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000886 | 0.0000886 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000112 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000384 | 0.0000353 |
Middle Eastern | 0.000112 | 0.000109 |
South Asian | 0.000297 | 0.000294 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates the intracellular transfer of ceramide-1- phosphate (C1P) between organelle membranes and the cell membrane. Required for normal structure of the Golgi stacks. Can bind phosphoceramides with a variety of aliphatic chains, but has a preference for lipids with saturated C16:0 or monounsaturated C18:1 aliphatic chains, and is inefficient with phosphoceramides containing lignoceryl (C24:0). Plays a role in the regulation of the cellular levels of ceramide-1-phosphate, and thereby contributes to the regulation of phospholipase PLA2G4A activity and the release of arachidonic acid. Has no activity with galactosylceramide, lactosylceramide, sphingomyelin, phosphatidylcholine, phosphatidic acid and ceramide. C1P transfer is stimulated by phosphatidylserine in C1P source vesicles (PubMed:28011644). Regulates autophagy, inflammasome mediated IL1B and IL18 processing, and pyroptosis, but not apoptosis (PubMed:29164996). {ECO:0000269|PubMed:23863933, ECO:0000269|PubMed:28011644, ECO:0000269|PubMed:29164996}.;
- Pathway
- Metabolism of lipids;Metabolism;Glycosphingolipid metabolism;Sphingolipid metabolism
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 61.73
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.292
- ghis
- 0.444
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Cptp
- Phenotype
Gene ontology
- Biological process
- glycosphingolipid metabolic process;negative regulation of autophagy;ceramide transport;glycolipid transport;negative regulation of interleukin-1 beta secretion;intermembrane lipid transfer;negative regulation of NLRP3 inflammasome complex assembly;ceramide 1-phosphate transport
- Cellular component
- nuclear outer membrane;Golgi apparatus;cytosol;plasma membrane;endosome membrane;membrane
- Molecular function
- phospholipid binding;phospholipid transporter activity;lipid binding;intermembrane lipid transfer activity;ceramide 1-phosphate binding;ceramide 1-phosphate transporter activity